⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRMD News
CorMedix Inc.
CREATE Medicines Receives Approval to Initiate First-in-Human Phase 1/2 Clinical Trial of In Vivo CAR-T Candidate CRT-402 for Autoimmune Diseases
prnewswire.com
CRMD
CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
globenewswire.com
CRMD
Form 8-K
sec.gov
CRMD
Form 8-K
sec.gov
CRMD
Form 8-K
sec.gov
CRMD
Within3 Appoints Erin Mistry as Chief Executive Officer
businesswire.com
CRMD
AZN
Clinical Decision Support System (CDSS) Market worth $10.15 billion by 2031 | MarketsandMarkets™
prnewswire.com
ORCL
MSFT
UNH
VERI
CRMD
GEHC
Form 8-K
sec.gov
CRMD
U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation
globenewswire.com
CRMD
Cormedix Therapeutics to Participate in two Upcoming Investor Conferences
globenewswire.com
CRMD